1 Study Coverage
1.1 Lung Cancer Diagnostics Revenue in Lung Cancer Diagnostics Business (2017-2022) & (US$ Million) Introduction
1.2 Global Lung Cancer Diagnostics Outlook 2017 VS 2022 VS 2028
1.2.1 Global Lung Cancer Diagnostics Market Size for the Year 2017-2028
1.2.2 Global Lung Cancer Diagnostics Market Size for the Year 2017-2028
1.3 Lung Cancer Diagnostics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Lung Cancer Diagnostics in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Lung Cancer Diagnostics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Lung Cancer Diagnostics Market Dynamics
1.4.1 Lung Cancer Diagnostics Industry Trends
1.4.2 Lung Cancer Diagnostics Market Drivers
1.4.3 Lung Cancer Diagnostics Market Challenges
1.4.4 Lung Cancer Diagnostics Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Lung Cancer Diagnostics by Type
2.1 Lung Cancer Diagnostics Market Segment by Type
2.1.1 Immunoassays
2.1.2 Flow Cytometry
2.1.3 Rapid Tests
2.1.4 Molecular Assays
2.1.5 Tissue Arrays
2.1.6 Circulating Tumor Cells
2.1.7 Pharmacodiagnostics
2.1.8 Biomarkers
2.1.9 Other
2.2 Global Lung Cancer Diagnostics Market Size by Type (2017, 2022 & 2028)
2.3 Global Lung Cancer Diagnostics Market Size by Type (2017-2028)
2.4 United States Lung Cancer Diagnostics Market Size by Type (2017, 2022 & 2028)
2.5 United States Lung Cancer Diagnostics Market Size by Type (2017-2028)
3 Lung Cancer Diagnostics by Application
3.1 Lung Cancer Diagnostics Market Segment by Application
3.1.1 Industrial
3.1.2 Healthcare
3.1.3 Other
3.2 Global Lung Cancer Diagnostics Market Size by Application (2017, 2022 & 2028)
3.3 Global Lung Cancer Diagnostics Market Size by Application (2017-2028)
3.4 United States Lung Cancer Diagnostics Market Size by Application (2017, 2022 & 2028)
3.5 United States Lung Cancer Diagnostics Market Size by Application (2017-2028)
4 Global Lung Cancer Diagnostics Competitor Landscape by Company
4.1 Global Lung Cancer Diagnostics Market Size by Company
4.1.1 Top Global Lung Cancer Diagnostics Companies Ranked by Revenue (2021)
4.1.2 Global Lung Cancer Diagnostics Revenue by Player (2017-2022)
4.2 Global Lung Cancer Diagnostics Concentration Ratio (CR)
4.2.1 Lung Cancer Diagnostics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Lung Cancer Diagnostics in 2021
4.2.3 Global Lung Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Lung Cancer Diagnostics Headquarters, Revenue in Lung Cancer Diagnostics Business (2017-2022) & (US$ Million) Type
4.3.1 Global Lung Cancer Diagnostics Headquarters and Area Served
4.3.2 Global Lung Cancer Diagnostics Companies Revenue in Lung Cancer Diagnostics Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Lung Cancer Diagnostics Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Lung Cancer Diagnostics Market Size by Company
4.5.1 Top Lung Cancer Diagnostics Players in United States, Ranked by Revenue (2021)
4.5.2 United States Lung Cancer Diagnostics Revenue by Players (2020, 2021 & 2022)
5 Global Lung Cancer Diagnostics Market Size by Region
5.1 Global Lung Cancer Diagnostics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Lung Cancer Diagnostics Market Size by Region (2017-2028)
5.2.1 Global Lung Cancer Diagnostics Market Size by Region: 2017-2022
5.2.2 Global Lung Cancer Diagnostics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Lung Cancer Diagnostics Market Size YoY Growth 2017-2028
6.1.2 North America Lung Cancer Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Lung Cancer Diagnostics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Lung Cancer Diagnostics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Lung Cancer Diagnostics Market Size YoY Growth 2017-2028
6.3.2 Europe Lung Cancer Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Lung Cancer Diagnostics Market Size YoY Growth 2017-2028
6.4.2 Latin America Lung Cancer Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Lung Cancer Diagnostics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Lung Cancer Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Roche Diagnostics
7.1.1 Roche Diagnostics Company Details
7.1.2 Roche Diagnostics Business Overview
7.1.3 Roche Diagnostics Lung Cancer Diagnostics Introduction
7.1.4 Roche Diagnostics Revenue in Lung Cancer Diagnostics Business (2017-2022)
7.1.5 Roche Diagnostics Recent Development
7.2 BioM?rieux
7.2.1 BioM?rieux Company Details
7.2.2 BioM?rieux Business Overview
7.2.3 BioM?rieux Lung Cancer Diagnostics Introduction
7.2.4 BioM?rieux Revenue in Lung Cancer Diagnostics Business (2017-2022)
7.2.5 BioM?rieux Recent Development
7.3 Qiagen
7.3.1 Qiagen Company Details
7.3.2 Qiagen Business Overview
7.3.3 Qiagen Lung Cancer Diagnostics Introduction
7.3.4 Qiagen Revenue in Lung Cancer Diagnostics Business (2017-2022)
7.3.5 Qiagen Recent Development
7.4 Advpharma
7.4.1 Advpharma Company Details
7.4.2 Advpharma Business Overview
7.4.3 Advpharma Lung Cancer Diagnostics Introduction
7.4.4 Advpharma Revenue in Lung Cancer Diagnostics Business (2017-2022)
7.4.5 Advpharma Recent Development
7.5 AIT Austrian Institute of Technology
7.5.1 AIT Austrian Institute of Technology Company Details
7.5.2 AIT Austrian Institute of Technology Business Overview
7.5.3 AIT Austrian Institute of Technology Lung Cancer Diagnostics Introduction
7.5.4 AIT Austrian Institute of Technology Revenue in Lung Cancer Diagnostics Business (2017-2022)
7.5.5 AIT Austrian Institute of Technology Recent Development
7.6 Courtagen Life Sciences
7.6.1 Courtagen Life Sciences Company Details
7.6.2 Courtagen Life Sciences Business Overview
7.6.3 Courtagen Life Sciences Lung Cancer Diagnostics Introduction
7.6.4 Courtagen Life Sciences Revenue in Lung Cancer Diagnostics Business (2017-2022)
7.6.5 Courtagen Life Sciences Recent Development
7.7 DiagnoCure
7.7.1 DiagnoCure Company Details
7.7.2 DiagnoCure Business Overview
7.7.3 DiagnoCure Lung Cancer Diagnostics Introduction
7.7.4 DiagnoCure Revenue in Lung Cancer Diagnostics Business (2017-2022)
7.7.5 DiagnoCure Recent Development
7.8 BioMark Diagnostics
7.8.1 BioMark Diagnostics Company Details
7.8.2 BioMark Diagnostics Business Overview
7.8.3 BioMark Diagnostics Lung Cancer Diagnostics Introduction
7.8.4 BioMark Diagnostics Revenue in Lung Cancer Diagnostics Business (2017-2022)
7.8.5 BioMark Diagnostics Recent Development
7.9 Mayo Clinic
7.9.1 Mayo Clinic Company Details
7.9.2 Mayo Clinic Business Overview
7.9.3 Mayo Clinic Lung Cancer Diagnostics Introduction
7.9.4 Mayo Clinic Revenue in Lung Cancer Diagnostics Business (2017-2022)
7.9.5 Mayo Clinic Recent Development
7.10 HalioDx SAS
7.10.1 HalioDx SAS Company Details
7.10.2 HalioDx SAS Business Overview
7.10.3 HalioDx SAS Lung Cancer Diagnostics Introduction
7.10.4 HalioDx SAS Revenue in Lung Cancer Diagnostics Business (2017-2022)
7.10.5 HalioDx SAS Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
